Barely Significant
← all excerpts

STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain.

Emerg Med J · 2014 · PMC4112448 · PMID 24743584

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp<0.0001actually significant
Overall, there was a highly significant difference between the methoxyflurane and placebo group (estimated treatment effect, −15.1 mm; 95% CI −19.2 to −11.0; p<0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.